David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’

GLP-1-driven demand is reshaping food consumption, with protein emerging as a key beneficiary as users seek to preserve muscle mass. David Protein expects about $300 million in revenue this year and now has products in roughly 16,000 stores, but whey input costs have risen from $7 to nearly $12 per pound and high-protein whey concentrate prices are up 40% in recent months. The article suggests a broader shift in food trends away from diet programs and toward protein-centric products, creating both demand growth and supply-chain pressure.

Analysis

GLP-1s are not just shifting basket composition; they are changing the elasticity of food demand toward a higher-protein, lower-volume regime. That favors brands with pricing power, formulation flexibility, and shelf-space density, while squeezing legacy “diet” franchises and any protein manufacturers tied to a single input. The most important second-order effect is that protein becomes less of a niche nutrition category and more of a structural grocery staple, which should support recurring volume growth even if broader snack demand softens.

The near-term bottleneck is whey, but the bigger margin risk sits in product architecture: if whey stays elevated for multiple quarters, premium protein brands may be forced to reformulate, shrink pack sizes, or accept gross margin compression. That creates a winner set in alternative proteins, ingredient distributors, and cold-chain/packaged-food suppliers that can reprice faster, while exposing companies that rely on a narrow ingredient stack. Over 3-12 months, the market will likely underappreciate how quickly this can become a deflationary event for whey if manufacturers pivot away en masse.

For Starbucks, this is less about today’s beverage mix and more about the optionality of protein add-ons and menu innovation. If protein-enhanced beverages prove sticky, SBUX can lift ticket without relying solely on traffic, and incremental customization typically carries better margin than core refreshment items. The risk is that proteinization is initially promotional rather than habitual; if consumers trial but do not repeat, the revenue uplift will be modest and mostly confined to a few quarters of novelty demand.

Morgan Stanley is a softer beneficiary: the investable angle is not direct revenue from consumer trends, but financing, healthcare coverage, and consumer balance-sheet substitution as GLP-1 adoption expands. The contrarian read is that the market may be overestimating the permanence of “proteinmaxxing” at current enthusiasm levels; if weight-loss drug access stabilizes and the initial adoption wave matures, protein growth could normalize faster than current ingredient pricing implies. Still, the supply chain can remain tight longer than sentiment, which creates a tactically attractive setup in commodity-sensitive names.

Key Decisions for Investors

• Long SBUX 3-6 months: buy on weakness or use call spreads to express upside from proteinized beverage innovation and menu margin mix; thesis works if protein customization becomes a repeat purchase behavior rather than a one-off launch.
• Long MS 6-12 months: modest overweight as a secondary beneficiary of broader GLP-1 adoption and consumer wallet reallocation; lower beta, but cleaner risk/reward than chasing pure-play food names at elevated multiples.
• Short a basket of whey-exposed protein brands or ingredient suppliers that cannot reprice quickly; use a 3-6 month horizon and target names with high single-source input dependence and limited hedge flexibility.
• Pair trade: long alternative protein / diversified ingredient exposure vs. short whey-dependent processors; the spread should widen if manufacturers begin reformulating away from whey over the next 2-4 quarters.
• If available in the consumer space, buy 6-12 month upside via call spreads on brands with credible GLP-1-specific product lines; the asymmetry is strong if shelf-space expansion persists, but cap premium paid because the trend may decelerate once novelty fades.